References
- M. Duvic, K. Hymes, P. Heald, D. Breneman, A.G. Martin, P. Myskowski, C. Crowley, R.C. Yocum, Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: Multinational Phase II-III trial results, Journal of Clinical Oncology 19 (2001) 2456–2471. DOI: 10.1200/JCO.2001.19.9.2456
- L.T. Farol, K.B. Hymes, Bexarotene: a clinical review, Expert Review of Anticancer Therapy 14 (2014) 180–188. DOI: 10.1586/14737140.4.2.180
- L. Qu, X. Tang, Bexarotene: a promising anticancer agent, Cancer Chemotherapy and Pharmacology 65 (2010) 201–205. DOI: 10.1007/s00280-009-1140-4
- C.R. Schadt, Topical and oral bexarotene, Dermatology and Therapy 26 (2013) 400–403. DOI: 10.1111/dth.12087
- T. Kobayashi, A. Mitsuhashi, H. Piao, M. Shioya, K. Kojima, K. Nishikimi, K. Yahiro, M. Shozu, Bexarotene-induced cell death in ovarian cancer cells through Caspase-4–gasdermin E mediated pyroptosis, Scientific Reports 12 (2022) 11123. DOI: 10.1038/s41598-022-15348-7
- Q. Zhang, S.B. Lee, X. Chen, M.E. Stevenson, J. Pan, D. Xiong, Y. Zhou, M.S. Miller, R.A. Lubet, Y. Wang, S.P. Mirza, M. You, Optimized bexarotene aerosol formulation inhibits major subtypes of lung cancer in mice, Nano Letters 19 (2019) 2231–2242. DOI: 10.1021/acs.nanolett.8b04309
- C.M. Ludwig, C. Wilson, B. Roman, M.M. Tsoukas, Mechanism of Action of Bexarotene, 1st ed., CRC Press, Boca Raton, 2019.
- C. Hacioglu, F. Kar, S. Kacar, M. Senturk, Bexarotene inhibits cell proliferation by inducing oxidative stress, DNA damage and apoptosis via PPARγ/NF-κB signaling pathway in C6 glioma cells, Medical Oncology 38 (2021) 31. DOI: 10.1007/s12032-021-01476-z
- W. Zha, Z. Wang, W. Hu, C. Ge, W. Yuan, Q. Shen, W. Li, W. Chen, J. Tang, Z. Xiao, Y. Meng, L. Huang, Z. Zhong, T.-S. Li, J. Chen, Z. Cao, Bexarotene regulates zebrafish embryonic development by activating Wnt signaling pathway, Life Sciences 373 (2025) 123664. DOI: 10.1016/j.lfs.2025.123664
- S.R. Howell, M.A. Shirley, T.A. Grese, D.A. Neel, K.E. Wells, E.H. Ulm, Bexarotene metabolism in rat, dog, and human: synthesis of oxidative metabolites and in vitro activity at retinoid receptors, Drug Metabolism and Disposition 29 (2001) 990–998.
- A. Husain, J. Monga, S. Narwal, G. Singh, M. Rashid, O. Afzal, A. Alatawi, N.M. Almadani, Prodrug rewards in medicinal chemistry: an advance and challenges approach for drug designing, Chemistry and Biodiversity 20 (2023) e202301169. DOI: 10.1002/cbdv.202301169
- J.B. Lee, A. Zgair, J. Malec, T.H. Kim, M.G. Kim, J. Ali, C. Qin, W. Feng, M. Chiang, X. Gao, G. Voronin, A.E. Garces, C.L. Lau, T.-H. Chan, A. Hume, T.M. McIntosh, F. Soukarieh, M. Al-Hayali, E. Cipolla, H.M. Collins, P. Gershkovich, Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system, Journal of Controlled Release 286 (2018) 10–19. DOI: 10.1016/j.jconrel.2018.07.022
- A.A. Bele, A. Khale, An overview of thin-layer chromatography, International Journal of Pharmaceutical Sciences and Research 2 (2011) 256–267.
- L.M. Ng, R. Simmons, Infrared spectroscopy, Analytical Chemistry 71 (1999) 343–350. DOI: 10.1021/a1999908r
- H. Förster, UV/VIS spectroscopy, in: J. Weitkamp, L. Puppe (Eds.), Molecular Sieves: Science and Technology, Vol. 4, Springer, Berlin, 2004, pp. 337–426.
- I.A. El-Sakka, N.A. Hassan, Synthetic uses of thionyl chloride, Journal of Sulfur Chemistry 26 (2005) 33–97. DOI: 10.1080/17415990500031187
- Merck KGaA, Safety Data Sheet: Thionyl chloride ≥ 98%, for synthesis, Darmstadt, Germany, 2024.
- I. Iliev, S. Georgieva, In silico methods for predicting physico-chemical properties and biological activity of newly synthesized esters of bexarotene, Bulgarian Chemical Communications 56 (2024) 77–94. DOI: 10.34049/bcc.56.D.S1P34
- C.E. Wagner, P.W. Jurutka, P.A. Marshall, A. Van Der Vaart, WO2011/103321 A1 – Novel bexarotene analogs, World Intellectual Property Organization, Patent Application, 25 Aug 2011.
- W. Lü, Q. Zhu, CN1429807 A – Synthesis of antitumour medicine bexarotene, China National Intellectual Property Administration, Patent Application, 28 May 2003.
- M.F. Boehm, L. Zhang, B.A. Badea, S.K. White, D.E. Mais, E. Berger, C.M. Suto, M.E. Goldman, R.A. Heyman, Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids, Journal of Medicinal Chemistry 37 (1994) 2930–2941. DOI: 10.1021/jm00044a014
- N. Agova, S. Georgieva, S. Stoeva, S. Stamova, J. Mitkov, HPLC method for analyzing new compounds – analogs of an antineoplastic drug, Bulgarian Chemical Communications 52 (2020) 09–16. DOI: 10.34049/bcc.52.A.271
- WO2011141928 A1 – Process for the preparation of highly pure bexarotene, inventors S.B. Bhirud, G.S. Sarin, B.K. Sharma, P. Gera, assignee Ind-Swift Laboratories Ltd., World Intellectual Property Organization, Patent Application, published 17 Nov 2011.
- Y. Zou, L. Qin, X. Ren, Y. Lu, Y. Li, J. (S.) Zhou, Selective arylation and vinylation at the α position of vinylarenes, Chemistry – A European Journal 19 (2013) 3504–3511. DOI: 10.1002/chem.201203646